MONTREAL, QUEBEC–(Marketwired – Nov. 3, 2016) – Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the “Company” or “Relevium”) is pleased to announce the launch of two wholly-owned subsidiaries: Relevium Wellness Inc. and Relevium E-Health Inc.
Relevium Wellness Inc. is a wholly owned subsidiary of Relevium and it was created to execute on the Company’s roll-up plans for existing physiotherapy clinics in Canada and the US. The Company is currently working on the development of its first clinic, which will serve as a pilot for testing the new service offerings and related operational technology. Once the concept has been proven, Relevium Wellness Inc. plans to identify and negotiate the acquisition of clinics in key strategic markets and integrating their clientele into its new Physiotherapy and Wellness service offering.
Relevium E-Health Inc. is a wholly-owned subsidiary and it was created to execute on the Company’s plans for consolidating successful entrepreneurial businesses offering proprietary health and wellness products, including nutraceuticals, supplements and other paramedic products sold predominantly online direct to consumers. As previously reported, the Company is in advanced discussions and negotiations with several targets in the lucrative, growing and largely fragmented health and wellness e-commerce markets.
Aurelio Useche, President and CEO stated: “The launch of these two wholly-owned entities will provide internal alignment and external clarity in terms of the execution of the Company’s corporate strategy. This is of particular importance as we pursue advanced discussions with several targets” Mr Useche stated further: “We endeavour to continue to provide our shareholders with updates on our progress and new developments as they take place”
Relevium is a TSXV listed company focused on growth through the acquisition of businesses, products and/or technologies within the scope of the expanding health and wellness sector, specifically under three important verticals: Pain Relief, Recovery and Performance. Relevium Technologies Inc. currently holds patented intellectual property for application of static magnetic fields on direct-to-consumer devices, which aid in decreasing pain, improving recovery time and enhancing overall physical performance.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
Aurelio Useche, CEO and Director
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the business and operations of the Company. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the ability of the Company to secure adequate funding in order to execute and achieve its business objectives. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. There can be no assurance that the conditions to the transactions contemplated by the potential letter of intents will be satisfied or that those transactions will be completed. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Relevium Technologies Inc.
SmallCapPower.com (SCP) is the industry’s most trusted resource for small cap stocks, offering unprecedented access to the research and tools you need to help uncover the next big thing.
Except for the historical information presented herein, matters discussed in this document contain forward- looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Ubika Research and www.smallcappower.com (are both divisions of Ubika Corporation), and are not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this report. For making specific investment decisions, readers should seek their own advice.
Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
For full disclosure please visit Here >>
For additional information contact:
Mark Thorburn- Manager, Media Relations